Legend Biotech (LEGN) Tops Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts LEGN Hot Sheet
Join SI Premium – FREE
Legend Biotech (NASDAQ: LEGN) reported Q2 EPS of ($0.05), $0.24 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $186.52 million versus the consensus estimate of $125.25 million.
For earnings history and earnings-related data on Legend Biotech (LEGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Teamshares begins trading on Nasdaq under ticker TMS
- Xerox Corp. (XRX) gains on report of SEWP VI contract
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
